BDTX - Black Diamond Therapeutics proposes $75M stock offering
2023-06-28 16:51:23 ET
-
Black Diamond Therapeutics ( NASDAQ: BDTX ) has planned a public offering of its common stock to raise $75 million, the company said Wednesday.
-
The underwriters will have a 30-day option to purchase up to an additional $11.25 million in shares.
-
The company said it will be selling all of the shares in the proposed offering.
-
Details on pricing and the number of shares to be sold in the offering were not disclosed.
-
Piper Sandler is acting as the sole bookrunner for the proposed offering.
-
Wedbush PacGrow is acting as the lead manager for the proposed offering.
-
Shares -11% at $5.10 after hours.
For further details see:
Black Diamond Therapeutics proposes $75M stock offering